Unique ID issued by UMIN | UMIN000045516 |
---|---|
Receipt number | R000051965 |
Scientific Title | Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study) |
Date of disclosure of the study information | 2021/10/20 |
Last modified on | 2024/03/22 11:52:36 |
Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study)
chronic postsurgical pain in TKA(medicine treatment)
Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study)
chronic postsurgical pain in TKA(medicine treatment)
Japan |
chronic postsurgical pain
Orthopedics |
Others
NO
Chronic postsurgical pain in TKA to OA will be the factor on which patient satisfaction is hung, and it's still lacking in evidence in what kind of medicine treatment there is a validity. It's the purpose of this research to make the validity of the medicine treatment clear. I can think these inspection results will be some help of establishment of a remedy to chronic postsurgical pain and improvement of treatment results of TKA.
Efficacy
The change which is sharp pain VAS in 3 months after the medicine treatment starting time and starting
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
3
Treatment
Medicine |
TRAMCET Combination Tablets
Cymbalta Capsules
TRAMCET Combination Tablets and Cymbalta Capsules
20 | years-old | <= |
Not applicable |
Male and Female
1)The patient who carried out TKA to OA
2)The patient who fills following all which is a definition of chronic postsurgical pain as of 3 months after an operation
1,The pain appears after surgery-like operation.
2,The pain is continuing for 2 months at least after an operation of TKA to OA.
3,The pain by the other cause can be excluded.
4,The pain besides the operation part which existed before the way can be excluded.
3)Patient who possesses sharp pain VAS >= 30 (0-100) as of 3 months after an operation
4)the patient of whom walking is independent
5)the age of the time of the agreement merit, more than 20-year-old patient(I don't ask about the gender.)
6)the patient who could get documentary consent by free will of the back and the patient person himself which had the enough explanation in case of participation of this research
1)the patient who is planning to carry out TKA in simultaneousness of left and right
2)patient with a spirit disease
3)patient with taboo and TRAMCET Combination Tablets and Cymbalta Capsules
4)additionally the patient who judged that a study person in charge was unsuitable as a subject of research person
105
1st name | Takeshi |
Middle name | |
Last name | Mochizuki |
Kamagaya General Hospital
Plastic surgery
273-0121
929-6 Hatsutomi, Kamagaya-City Chiba
047-498-8266
chiken@kamagaya-hp.jp
1st name | Takeshi |
Middle name | |
Last name | Mochizuki |
Kamagaya General Hospital
Plastic surgery
273-0121
929-6 Hatsutomi, Kamagaya-City Chiba
047-498-8266
chiken@kamagaya-hp.jp
Kamagaya General Hospital
Kamagaya General Hospital
Self funding
The TOKUSHUKAI GROUP ETHICS COMMITTEE
1-3-1 Kudanminami, Chiyoda-ku, Tokyo
03-3263-4801
mirai-ec4@mirai-iryo.com
NO
2021 | Year | 10 | Month | 20 | Day |
Unpublished
Enrolling by invitation
2021 | Year | 08 | Month | 27 | Day |
2021 | Year | 10 | Month | 13 | Day |
2021 | Year | 10 | Month | 13 | Day |
2026 | Year | 03 | Month | 31 | Day |
2021 | Year | 09 | Month | 18 | Day |
2024 | Year | 03 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051965